Find Research outputs

Search results

• A phase II trial of bevacizumab plus temsirolimus in patients with advanced hepatocellular carcinoma

  Knox, J. J., Qin, R., Strosberg, J. R., Tan, B., Kaubisch, A., El-Khoueiry, A. B., Bekaii-Saab, T. S., Rousey, S. R., Chen, H. X. & Erlichman, C., Feb 2015, In: Investigational New Drugs. 33, 1, p. 241-246 6 p.

  Research output: Contribution to journal › Article › peer-review
  28 Scopus citations

• A phase II trial of a surgical protocol to decrease the incidence of wound complications in obese gynecologic oncology patients

  Novetsky, A. P., Zighelboim, I., Guntupalli, S. R., Ioffe, Y. J. M., Kizer, N. T., Hagemann, A. R., Powell, M. A., Thaker, P. H., Mutch, D. G. & Massad, L. S., Aug 2014, In: Gynecologic Oncology. 134, 2, p. 233-237 5 p.

  Research output: Contribution to journal › Article › peer-review
  16 Scopus citations

• A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia

  Litzow, M. R., Lee, S., Bennett, J. M., Dewald, G. W., Gallagher, R. E., Jain, V., Paietta, E. M., Racevskis, J., Rousey, S. R., Mazza, J. J. & Tallman, M. S., Aug 2006, In: Haematologica. 91, 8, p. 1105-1108 4 p.

  Research output: Contribution to journal › Article › peer-review
  16 Scopus citations

• A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy

  Navid, F., Santana, V. M., Neel, M., McCarville, M. B., Shulkin, B. L., Wu, J., Billups, C. A., Mao, S., Daryani, V. M., Stewart, C. F., Kunkel, M., Smith, W., Ward, D., Pappo, A. S., Bahrami, A., Loeb, D. M., Reikes Willert, J., Rao, B. N. & Daw, N. C., Oct 1 2017, In: International Journal of Cancer. 141, 7, p. 1469-1477 9 p.

  Research output: Contribution to journal › Article › peer-review
  32 Scopus citations

• A phase II study of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine and ovarian cancers

  Gupta, D., Owers, R. L., Kim, M., Kuo, D. Y. S., Huang, G. S., Shahabi, S., Goldberg, G. L. & Einstein, M. H., Jun 2009, In: Gynecologic Oncology. 113, 3, p. 327-330 4 p.

  Research output: Contribution to journal › Article › peer-review
  14 Scopus citations

• A phase II study of taxol in patients with malignant melanoma

  Einzig, A. I., Hochster, H., Wiernik, P. H., Trump, D. L., Dutcher, J. P., Garowski, E., Sasloff, J. & Smith, T. J., Feb 1991, In: Investigational New Drugs. 9, 1, p. 59-64 6 p.

  Research output: Contribution to journal › Article › peer-review
  167 Scopus citations

• A phase II study of rebeccamycin analog NSC 655649 in patients with metastatic colorectal cancer

  Goel, S., Wadler, S., Hoffman, A., Volterra, F., Baker, C., Nazario, E., Ivy, P., Silverman, A. & Mani, S., Feb 2003, In: Investigational New Drugs. 21, 1, p. 103-107 5 p.

  Research output: Contribution to journal › Article › peer-review
  14 Scopus citations

• A phase ii study of pelareorep (REOLYSIN®) in combination with gemcitabine for patients with advanced pancreatic adenocarcinoma

  Mahalingam, D., Goel, S., Aparo, S., Arora, S. P., Noronha, N., Tran, H., Chakrabarty, R., Selvaggi, G., Gutierrez, A., Coffey, M., Nawrocki, S. T., Nuovo, G. & Mita, M. M., Jun 2018, In: Cancers. 10, 6, 160.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  72 Scopus citations

• A phase II study of high‐dose estrogens (diethylstilbestrol diphosphate) in prostate cancer

  Citrin, D. L., Kies, M. S., Wallemark, CB. B., Khandekar, J., Kaplan, E., Camacho, F. & Lind, R., Aug 1 1985, In: Cancer. 56, 3, p. 457-460 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  26 Scopus citations

• A phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanoma

  Dutcher, J. P., Gaynor, E. R., Boldt, D. H., Doroshow, J. H., Bar, M. H., Sznol, M., Mier, J., Sparano, J., Fisher, R. I., Weiss, G., Margolin, K., Aronson, F. R., Hawkins, M. & Atkins, M., 1991, In: Journal of Clinical Oncology. 9, 4, p. 641-648 8 p.

  Research output: Contribution to journal › Article › peer-review
  19 Scopus citations

• A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma

  Anderson, P. M., Bielack, S. S., Gorlick, R. G., Skubitz, K., Daw, N. C., Herzog, C. E., Monge, O. R., Lassaletta, A., Boldrini, E., Pápai, Z., Rubino, J., Pathiraja, K., Hille, D. A., Ayers, M., Yao, S. L., Nebozhyn, M., Lu, B. & Mauro, D., Oct 1 2016, In: Pediatric Blood and Cancer. 63, 10, p. 1761-1770 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  63 Scopus citations

• A phase II study of BEZ235 in patients with everolimusresistant, advanced pancreatic neuroendocrine tumours

  Fazio, N., Buzzoni, R., Baudin, E., Antonuzzo, L., Hubner, R. A., Lahner, H., De Herder, W. W., Raderer, M., Teulé, A., Capdevila, J., Libutti, S. K., Kulke, M. H., Shah, M., Dey, D., Turri, S., Aimone, P., Massacesi, C. & Verslype, C., Feb 2016, In: Anticancer Research. 36, 2, p. 713-720 8 p.

  Research output: Contribution to journal › Article › peer-review
  72 Scopus citations

• A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer

  Lacouture, M. E., Keefe, D. M., Sonis, S., Jatoi, A., Gernhardt, D., Wang, T., Doherty, J. P., Giri, N., Nadanaciva, S., O'Connell, J., Sbar, E., Piperdi, B. & Garon, E. B., Sep 1 2016, In: Annals of Oncology. 27, 9, p. 1712-1718 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  43 Scopus citations

• A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema

  Katz, B., Oct 2005, In: Ophthalmology. 112, 10, p. 1747-1757 11 p.

  Research output: Contribution to journal › Article › peer-review
  541 Scopus citations

• A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

  Tu, Y., Hershman, D. L., Bhalla, K., Fiskus, W., Pellegrino, C. M., Andreopoulou, E., Makower, D., Kalinsky, K., Fehn, K., Fineberg, S., Negassa, A., Montgomery, L. L., Wiechmann, L. S., Alpaugh, R. K., Huang, M. & Sparano, J. A., Jul 2014, In: Breast Cancer Research and Treatment. 146, 1, p. 145-152 8 p.

  Research output: Contribution to journal › Article › peer-review
  43 Scopus citations

• A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver

  Alexander, H. R., Libutti, S. K., Bartlett, D. L., Puhlmann, M., Fraker, D. L. & Bachenheimer, L. C., Aug 1 2000, In: Clinical Cancer Research. 6, 8, p. 3062-3070 9 p.

  Research output: Contribution to journal › Article › peer-review
  130 Scopus citations

• A phase I-II study of combined blockade of the ErbB receptor network with trastuzumab and gefitinib in patients with HER2 (ErbB2)-overexpressing metastatic breast cancer

  Arteaga, C. L., O'Neill, A., Moulder, S. L., Pins, M., Sparano, J. A., Sledge, G. W. & Davidson, N. E., Oct 1 2008, In: Clinical Cancer Research. 14, 19, p. 6277-6283 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  66 Scopus citations

• A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy

  Gralla, R. J., Bosnjak, S. M., Hontsa, A., Balser, C., Rizzi, G., Rossi, G., Borroni, M. E. & Jordan, K., Jul 2014, In: Annals of Oncology. 25, 7, p. 1333-1339 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  146 Scopus citations

• A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass

  Avidan, M. S., Levy, J. H., Scholz, J., Delphin, E., Rosseel, P. M. J., Howie, M. B., Gratz, I., Bush, C. R., Skubas, N., Aldea, G. S., Licina, M., Bonfiglio, L. J., Kajdasz, D. K., Ott, E. & Despotis, G. J., Feb 1 2005, In: Anesthesiology. 102, 2, p. 276-284 9 p.

  Research output: Contribution to journal › Article › peer-review
  101 Scopus citations

• A Phase II clinical trial of interleukin-2 and lymphokine-activated killer cells in advanced colorectal carcinoma

  Hawkins, M. J., Atkins, M. B., Dutcher, J. P., Fisher, R. I., Weiss, G. R., Margolin, K. A., Rayner, A. A., Sznol, M., Parkinson, D. R., Paietta, E., Gaynor, E. R., Boldt, D. H., Doroshow, J. H. & Aronson, F. R., Jan 1994, In: Journal of Immunotherapy. 15, 1, p. 74-78 5 p.

  Research output: Contribution to journal › Article › peer-review
  28 Scopus citations

• A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine

  Voss, T., Lipton, R. B., Dodick, D. W., Dupre, N., Ge, J. Y., Bachman, R., Assaid, C., Aurora, S. K. & Michelson, D., Aug 1 2016, In: Cephalalgia. 36, 9, p. 887-898 12 p.

  Research output: Contribution to journal › Article › peer-review
  186 Scopus citations

• A phase II, open-label study of ramucirumab in combination with paclitaxel and carboplatin as first-line therapy in patients with stage IIIB/IV non-small-cell lung cancer

  Camidge, D. R., Berge, E. M., Doebele, R. C., Ballas, M. S., Jahan, T., Haigentz, M., Hoffman, D., Spicer, J., West, H., Lee, P., Yang, L., Joshi, A., Gao, L., Yurasov, S. & Mita, A., Oct 1 2014, In: Journal of Thoracic Oncology. 9, 10, p. 1532-1539 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  49 Scopus citations

• A Phase i Clinical Trial of the Phosphatidylserine-targeting Antibody Bavituximab in Combination with Radiation Therapy and Capecitabine in the Preoperative Treatment of Rectal Adenocarcinoma

  Meyer, J., Arriaga, Y., Anandam, J., Karri, S., Syed, S., Verma, U., Abdelnaby, A., Raja, G., Dong, Y., Beg, M. S. & Balch, G., Oct 1 2018, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 10, p. 972-976 5 p.

  Research output: Contribution to journal › Article › peer-review
  5 Scopus citations

• A phase I clinical trial of prolonged infusion of hydroxyurea in combination with hyperfractionated, accelerated, external radiation therapy in patients with advanced squamous cell cancer of the head and neck

  Beitler, J. J., Smith, R. V., Haynes, H., Silver, C. E., Quish, A., Kotz, T., Serrano, M., Brook, A. & Wadler, S., 1998, In: Investigational New Drugs. 16, 2, p. 161-169 9 p.

  Research output: Contribution to journal › Article › peer-review
  18 Scopus citations

• A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer

  Murren, J., Modiano, M., Kummar, S., Clairmont, C., Egorin, M., Chu, E. & Sznol, M., Apr 2005, In: Investigational New Drugs. 23, 2, p. 123-135 13 p.

  Research output: Contribution to journal › Article › peer-review
  20 Scopus citations

• A phase I/II trial of vandetanib for patients with recurrent malignant glioma

  Kreisl, T. N., McNeill, K. A., Sul, J., Iwamoto, F. M., Shih, J. & Fine, H. A., Dec 2012, In: Neuro-Oncology. 14, 12, p. 1519-1526 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  70 Scopus citations

• A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104)

  Goldstein, L. J., Zhao, F., Wang, M., Swaby, R. F., Sparano, J. A., Meropol, N. J., Bhalla, K. N., Pellegrino, C. M., Katherine Alpaugh, R., Falkson, C. I., Klein, P. & Sledge, G. W., Sep 1 2017, In: Breast Cancer Research and Treatment. 165, 2, p. 375-382 8 p.

  Research output: Contribution to journal › Article › peer-review
  18 Scopus citations

• A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer

  Morris, M. J., Eisenberger, M. A., Pili, R., Denmeade, S. R., Rathkopf, D., Slovin, S. F., Farrelly, J., Chudow, J. J., Vincent, M., Scher, H. I. & Carducci, M. A., Oct 2012, In: Annals of Oncology. 23, 10, p. 2714-2719 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  29 Scopus citations

• A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: A trial by the Eastern Cooperative Oncology Group

  Rowe, J. M., Neuberg, D., Friedenberg, W., Bennett, J. M., Paietta, E., Makary, A. Z., Liesveld, J. L., Abboud, C. N., Dewald, G., Hayes, F. A., Tallman, M. S. & Wiernik, P. H., Jan 15 2004, In: Blood. 103, 2, p. 479-485 7 p.

  Research output: Contribution to journal › Article › peer-review
  235 Scopus citations

• A phase 2 trial of regorafenib as a single agent in patients with chemotherapy-refractory, advanced, and metastatic biliary tract adenocarcinoma

  Sun, W., Patel, A., Normolle, D., Patel, K., Ohr, J., Lee, J. J., Bahary, N., Chu, E., Streeter, N. & Drummond, S., Mar 15 2019, In: Cancer. 125, 6, p. 902-909 8 p.

  Research output: Contribution to journal › Article › peer-review
  73 Scopus citations

• A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression

  Nagele, P., Palanca, B. J., Gott, B., Brown, F., Barnes, L., Nguyen, T., Xiong, W., Salloum, N. C., Espejo, G. D., Lessov-Schlaggar, C. N., Jain, N., Cheng, W. W. L., Komen, H., Yee, B., Bolzenius, J. D., Janski, A., Gibbons, R., Zorumski, C. F. & Conway, C. R., Jun 9 2021, In: Science translational medicine. 13, 597, eabe1376.

  Research output: Contribution to journal › Article › peer-review
  20 Scopus citations

• A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancer

  Mayer, E. L., Baurain, J. F., Sparano, J., Strauss, L., Campone, M., Fumoleau, P., Rugo, H., Awada, A., Sy, O. & Llombart-Cussac, A., Nov 1 2011, In: Clinical Cancer Research. 17, 21, p. 6897-6904 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  83 Scopus citations

• A phase 2 study of radio frequency interstitial tissue ablation of localized renal tumors

  Walther, M. M., Shawker, T. H., Libutti, S. K., Lubensky, I., Choyke, P. L., Venzon, D. & Linehan, W. M., May 2000, In: Journal of Urology. 163, 5, p. 1424-1427 4 p.

  Research output: Contribution to journal › Article › peer-review
  65 Scopus citations

• A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: A Children's Oncology Group study

  Horton, T. M., Drachtman, R. A., Chen, L., Cole, P. D., Mccarten, K., Voss, S., Guillerman, R. P., Buxton, A., Howard, S. C., Hogan, S. M., Sheehan, A. M., López-Terrada, D., Mrazek, M. D., Agrawal, N., Wu, M. F., Liu, H., De Alarcon, P. A., Trippet, T. M. & Schwartz, C. L., Jul 1 2015, In: British Journal of Haematology. 170, 1, p. 118-122 5 p.

  Research output: Contribution to journal › Article › peer-review
  21 Scopus citations

• A phase 1 randomized study of hemodynamic effects and pharmacokinetic interactions during concomitant use of rimegepant and sumatriptan in healthy adults

  Croop, R., Ivans, A., Anderson, M. S., Stringfellow, J., Bertz, R., Hanna, M., Healy, F., Stock, D. A., Coric, V. & Lipton, R. B., 2021, In: Cephalalgia Reports. 4

  Research output: Contribution to journal › Article › peer-review

  Open Access
  6 Scopus citations

• A phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring

  Keller, M. J., Mesquita, P. M., Marzinke, M. A., Teller, R., Espinoza, L., Atrio, J. M., Lo, Y., Frank, B., Srinivasan, S., Fredricks, D. N., Rabe, L., Anderson, P. L., Hendrix, C. W., Kiser, P. F. & Herold, B. C., Mar 13 2016, In: AIDS. 30, 5, p. 743-751 9 p.

  Research output: Contribution to journal › Article › peer-review
  25 Scopus citations

• A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors

  Ghamande, S., Lin, C. C., Cho, D. C., Shapiro, G. I., Kwak, E. L., Silverman, M. H., Tseng, Y., Kuo, M. W., Mach, W. B., Hsu, S. C., Coleman, T., Yang, J. C. H., Cheng, A. L., Ghalib, M. H., Chuadhary, I. & Goel, S., Jun 2014, In: Investigational New Drugs. 32, 3, p. 445-451 7 p.

  Research output: Contribution to journal › Article › peer-review
  20 Scopus citations

• A phase 1 open-label, accelerated dose-escalation study of the hypoxia-activated prodrug AQ4N in patients with advanced malignancies

  Papadopoulos, K. P., Goel, S., Beeram, M., Wong, A., Desai, K., Haigentz, M., Milián, M. L., Mani, S., Tolcher, A., Lalani, A. S. & Sarantopoulos, J., Nov 1 2008, In: Clinical Cancer Research. 14, 21, p. 7110-7115 6 p.

  Research output: Contribution to journal › Article › peer-review
  42 Scopus citations

• A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes

  Sekeres, M. A., Schuster, M., Joris, M., Krauter, J., Maertens, J., Breems, D., Gyan, E., Kovacsovics, T., Verma, A., Vyas, P., Wang, E. S., Ching, K., O’Brien, T., Gallo Stampino, C., Ma, W. W., Kudla, A., Chan, G. & Zeidan, A. M., Aug 2022, In: Annals of Hematology. 101, 8, p. 1689-1701 13 p.

  Research output: Contribution to journal › Article › peer-review
  3 Scopus citations

• A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma

  Chawla, S. P., Goel, S., Chow, W., Braiteh, F., Singh, A. S., Grilley Olson, J. E., Osada, A., Bobe, I. & Riedel, R. F., Aug 15 2020, In: Clinical Cancer Research. 26, 16, p. 4225-4232 8 p.

  Research output: Contribution to journal › Article › peer-review
  14 Scopus citations

• A phase 1b/pharmacokinetic trial of PTC299, a novel posttranscriptional VEGF inhibitor, for AIDS-related Kaposi's Sarcoma: AIDS malignancy consortium trial 059

  for the AIDS Malignancy Consortium (AMC)-059 Study Team, May 1 2016, In: Journal of Acquired Immune Deficiency Syndromes. 72, 1, p. 52-57 6 p.

  Research output: Contribution to journal › Article › peer-review
  8 Scopus citations

• A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer

  Goel, S., Swami, U., Kumar, K., Dittrich, C., Reyderman, L., Jain, M., Aisner, J., Song, J. & Petrylak, D. P., Sep 1 2019, In: Cancer Chemotherapy and Pharmacology. 84, 3, p. 567-578 12 p.

  Research output: Contribution to journal › Article › peer-review
  2 Scopus citations

• A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer

  ETCTN-8282 study team, May 2022, In: Cancer Chemotherapy and Pharmacology. 89, 5, p. 721-735 15 p.

  Research output: Contribution to journal › Article › peer-review
  2 Scopus citations

• A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061

  Rudek, M. A., Moore, P. C., Mitsuyasu, R. T., Dezube, B. J., Aboulafia, D., Gerecitano, J., Sullivan, R., Cianfrocca, M. E., Henry, D. H., Ratner, L., Haigentz, M., Dowlati, A., Little, R. F., Ivy, S. P. & Deeken, J. F., Apr 15 2014, In: Cancer. 120, 8, p. 1194-1202 9 p.

  Research output: Contribution to journal › Article › peer-review
  27 Scopus citations

• A pharmacogenetic versus a clinical algorithm for warfarin dosing

  Kimmel, S. E., French, B., Kasner, S. E., Johnson, J. A., Anderson, J. L., Gage, B. F., Rosenberg, Y. D., Eby, C. S., Madigan, R. A., McBane, R. B., Abdel-Rahman, S. Z., Stevens, S. M., Yale, S., Mohler, E. R., Fang, M. C., Shah, V., Horenstein, R. B., Limdi, N. A., Muldowney, J. A. S., Gujral, J., & 11 othersDelafontaine, P., Desnick, R. J., Ortel, T. L., Billett, H. H., Pendleton, R. C., Geller, N. L., Halperin, J. L., Goldhaber, S. Z., Caldwell, M. D., Califf, R. M. & Ellenberg, J. H., 2013, In: New England Journal of Medicine. 369, 24, p. 2283-2293 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  615 Scopus citations

• A phantom study to evaluate three different registration platform of 3D/3D, 2D/3D, and 3D surface match with 6D alignment for precise image-guided radiotherapy

  Kuo, H. C., Lovelock, M. M., Li, G., Ballangrud, Å., Wolthuis, B., Della Biancia, C., Hunt, M. A. & Berry, S. L., Dec 2020, In: Journal of Applied Clinical Medical Physics. 21, 12, p. 188-196 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  3 Scopus citations

• A petition for all patients with hidradenitis suppurativa to receive the HPV vaccine

  Deutsch, A., Cohen, S. R. & Blasiak, R. C., 2021, In: Acta Oncologica. 60, 1, p. 50-51 2 p.

  Research output: Contribution to journal › Letter › peer-review
  1 Scopus citations

• A Perspective on the Potential Involvement of Impaired Proteostasis in Neuropsychiatric Disorders

  Hui, K. K., Endo, R., Sawa, A. & Tanaka, M., Feb 15 2022, In: Biological Psychiatry. 91, 4, p. 335-345 11 p.

  Research output: Contribution to journal › Review article › peer-review
  1 Scopus citations

• A perspective on progress and gaps in HIV prevention science

  Kiser, P. F., Mesquita, P. M. M. & Herold, B. C., Nov 1 2012, In: AIDS Research and Human Retroviruses. 28, 11, p. 1373-1378 6 p.

  Research output: Contribution to journal › Review article › peer-review
  9 Scopus citations

• A perspective on oxygenated species in the refinery integration of pyrolysis oil

  Talmadge, M. S., Baldwin, R. M., Biddy, M. J., McCormick, R. L., Beckham, G. T., Ferguson, G. A., Czernik, S., Magrini-Bair, K. A., Foust, T. D., Metelski, P. D., Hetrick, C. & Nimlos, M. R., Feb 2014, In: Green Chemistry. 16, 2, p. 407-453 47 p.

  Research output: Contribution to journal › Review article › peer-review
  214 Scopus citations